Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/03/21/2850139/0/en/IntelGenx-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results.html
https://www.globenewswire.com//news-release/2024/03/11/2843679/0/en/IntelGenx-Enters-Into-a-Third-Amended-and-Restated-Loan-Agreement-With-atai-Life-Sciences.html
https://www.globenewswire.com//news-release/2024/02/05/2823485/0/en/Studies-Validate-Advantages-of-Administering-Drugs-to-Pets-via-IntelGenx-s-VetaFilm-Platform.html
https://www.globenewswire.com//news-release/2023/12/18/2797713/0/en/IntelGenx-Announces-New-Animal-Health-Partnership-Enters-into-Development-and-License-Agreements-for-VetaFilm.html
https://www.globenewswire.com/news-release/2023/12/05/2790856/0/en/IntelGenx-Announces-Closing-of-Previously-Announced-Subsequent-Non-Brokered-Private-Placement-With-atai-Life-Sciences-for-Aggregate-Gross-Proceeds-of-US-750-000.html
https://www.globenewswire.com//news-release/2023/11/28/2787357/0/en/IntelGenx-Announces-Shareholder-Approval-of-Financing-Transactions.html
https://www.globenewswire.com//news-release/2023/11/14/2779952/0/en/IntelGenx-Receives-Approval-to-Conduct-MONTPARK-Montelukast-VersaFilm-Phase-2-Clinical-Trial-in-Patients-with-Parkinson-s-Disease.html
https://www.globenewswire.com//news-release/2023/11/13/2778971/0/en/IntelGenx-Reminds-Shareholders-to-Vote-at-Upcoming-Special-Meeting.html
https://www.contractpharma.com/contents/view_breaking-news/2023-08-11/intelgenx-reports-first-agreement-for-cdmo-packagi/
https://www.globenewswire.com//news-release/2023/11/06/2774125/0/en/IntelGenx-Announces-Co-development-and-Commercialization-of-Cannabinoid-Infused-VersaFilm-Products-with-Tilray.html